SCHEMBL7676699

SCHEMBL7676699

NC(=O)C1(C(=O)OCc2ccccc2)CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.46
▸ ITGAV P06756 2/20 0.46
▸ GRIN2B Q13224 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KCNH2 Q12809 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ SMN1; SMN2 Q16637 7/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ NPC1 O15118 6/20 0.41
▸ PKM P14618 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693183 0.91 KCNH2 (0.45) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL5790495 0.73 DDB1 (0.51) ALDH1A1MAPK1SMN1; SMN2CYP2C19TDP1
SCHEMBL28406604 0.71 HDAC6 (0.57) KCNH2SMN1; SMN2RAB9ANPC1POLB
SCHEMBL7544328 0.71 SMN1; SMN2 (0.63) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL7082045 0.71 SMN1; SMN2 (0.63) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL7172907 0.71 SMN1; SMN2 (0.63) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL7085654 0.70 SMN1; SMN2 (0.59) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL7085647 0.70 SMN1; SMN2 (0.59) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL7089468 0.70 SMN1; SMN2 (0.59) ITGB3ITGAVALDH1A1MAPK1HSD17B10
SCHEMBL6025081 0.70 DDB1 (0.48) ALDH1A1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 — — US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US disclosed
Send feedback